Literature DB >> 10048495

The natriuretic peptide system in obesity-related hypertension: new pathophysiological aspects.

P Dessì-Fulgheri1, R Sarzani, A Rappelli.   

Abstract

The association between obesity and hypertension is well known but the pathophysiology of weight-related changes on blood pressure is still a matter of debate. Although obesity-related hypertension is considered to be sodium-sensitive, little attention has been given to a possible pathophysiological role of Atrial Natriuretic Peptides (ANP) and their receptors (NPr) system. Since the early phase of weight loss induced by very-low-calorie diet or fasting is followed by a significant increase in diuresis and natriuresis together with an increase in circulating ANP, we focused our attention on the possible role of adipose tissue in mediating these changes. We first demonstrated that human and rat adipose tissue contain high levels of mRNA specific for both type A (NPr-A), which is biologically active, and type C (NPr-C) which is biologically inactive, receptors. We then demonstrated in the rat that fasting exerts a tissue-specific and gene-specific suppression of NPr-C gene expression in adipose tissue that appears to be accompanied by an increased biological activity of ANP. These experimental observations were confirmed in man studying gene expression of NPr-A and NPr-C in adipose tissue obtained through subcutaneous peri-umbilical needle aspiration in obese and non-obese hypertensive patients. We found that NPr-A: NPr-C mRNA ratio was significantly lower in obese hypertensive patients as compared with non-obese hypertensives. These findings suggest that overxpression of the clearance receptor in the obese may trap more molecules of circulating ANP so reducing their biological activity at renal level. More recent results were obtained in obese hypertensive patients in whom the intravenous bolus injection of ANP (0.6 mg/kg body weight) was performed before and after four days of very-low-calorie diet which induced a weight loss accompanied by a significant reduction of BP and an increase in the urinary excretion of cGMP. The infusion of ANP after low-calorie diet was followed by an increase of ANP levels similar to that observed before diet, but plasma cGMP, diuresis and natriuresis significantly increased only after caloric restriction and the effects of ANP infusion on BP were more pronounced. Taken together our studies suggest that the abundance of NPr-C in adipose tissue may play a significant role in explaining at least part of the sodium retention characteristic of obesity associated hypertension.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10048495

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  16 in total

Review 1.  A heart-adipose tissue connection in the regulation of energy metabolism.

Authors:  Sheila Collins
Journal:  Nat Rev Endocrinol       Date:  2013-12-03       Impact factor: 43.330

Review 2.  The paradox of low BNP levels in obesity.

Authors:  Aldo Clerico; Alberto Giannoni; Simona Vittorini; Michele Emdin
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 3.  The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches.

Authors:  Zohreh Soltani; Vaughn Washco; Stephen Morse; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

Review 4.  Morbid obesity: obscuring the diagnosis of aortic stenosis in a patient with cardiogenic wheezing.

Authors:  Eric D Morrell; William E Katz; Asher A Tulsky
Journal:  J Gen Intern Med       Date:  2012-07-19       Impact factor: 5.128

5.  Evolution of Paroxysmal Atrial Fibrillation to Persistent or Permanent Atrial Fibrillation: Predictors of Progression.

Authors:  Jayasree Pillarisetti; Akshar Patel; Kenneth Boc; Sudharani Bommana; Youssef Sawers; Subbareddy Vanga; Hari Sayana; Warren Chen; Jayanth Nath; James Vacek; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2009-06-01

Review 6.  Hypertension in patients presenting with stroke.

Authors:  B J Pearson; P M Bath; J D Spence
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

7.  Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years.

Authors:  Teresa S M Tsang; Marion E Barnes; Yoko Miyasaka; Stephen S Cha; Kent R Bailey; Grace C Verzosa; James B Seward; Bernard J Gersh
Journal:  Eur Heart J       Date:  2008-07-08       Impact factor: 29.983

8.  Resistin, adiponectin, and risk of heart failure the Framingham offspring study.

Authors:  David S Frankel; Ramachandran S Vasan; Ralph B D'Agostino; Emelia J Benjamin; Daniel Levy; Thomas J Wang; James B Meigs
Journal:  J Am Coll Cardiol       Date:  2008-12-26       Impact factor: 24.094

9.  Association of plasma B-type natriuretic peptide concentrations with longitudinal blood pressure tracking in African Americans: findings from the Jackson Heart Study.

Authors:  Ervin R Fox; Solomon K Musani; Preeti Singh; Aurelian Bidulescu; Harsha S Nagarajarao; Tandaw E Samdarshi; Michael W Steffes; Thomas J Wang; Herman A Taylor; Ramachandran S Vasan
Journal:  Hypertension       Date:  2012-11-26       Impact factor: 10.190

10.  Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity.

Authors:  Kazutoshi Miyashita; Hiroshi Itoh; Hirokazu Tsujimoto; Naohisa Tamura; Yasutomo Fukunaga; Masakatsu Sone; Kenichi Yamahara; Daisuke Taura; Megumi Inuzuka; Takuhiro Sonoyama; Kazuwa Nakao
Journal:  Diabetes       Date:  2009-08-18       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.